Ignite Proteomics offers the only commercially available and clinically validated assay that measures both the expression and ...

Nurix Therapeutics, Inc. (NASDAQ:NRIX), a biopharmaceutical company specializing in protein degradation therapies, has been ...

Since 2007, the contract laboratory Alphalyse A/S has developed and refined a new method of impurity analysis in biological ...

Protein ubiquitination profiling in human pituitary and PAs remains unknown. Here, we performed the first ubiquitination analysis with an anti-ubiquitin antibody (specific to K-ε-GG)-based label-free ...

MudPIT was applied to the proteome of the Saccharomyces cerevisiae strain BJ5460 grown to mid-log phase and yielded the largest proteome analysis to date. A total of 1,484 proteins were detected ...

Single-cell protein analysis has emerged as a powerful tool for understanding cellular heterogeneity and deciphering the complex mechanisms governing cellular function and fate. This review provides a ...

InvestingPro analysis confirms the company's solid financial ... Nurix operates in a competitive biotech landscape, particularly in the field of protein degradation therapies.

Both high-protein and low-carb diets are effective for weight loss. Consuming more protein may be the most important factor ...

Announcing a new publication for Acta Materia Medica journal. Single-cell RNA sequencing (scRNA-seq) data from published datasets were obtained to investigate the expression and dysregulation of ...

Biopharmaceuticals and biotherapeutics are medicines produced from living cells. But cells produce other proteins (called host cell proteins, or HCPs) that can contaminate the final therapeutic ...

Researchers have discovered clear chemical traces of decaying collagen in a duck-billed dinosaur fossil, upending previously ...